These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 17493549)

  • 21. [Microalbuminuria: its pathophysiology, diagnostic significance and the methods of its study].
    Titov VN; Tarasov AV
    Ter Arkh; 1988; 60(6):134-40. PubMed ID: 3061047
    [No Abstract]   [Full Text] [Related]  

  • 22. Does bacteriuria interfere with albuminuria measurements of patients with diabetes?
    Kramer CK; Camargo J; Ricardo ED; Almeida FK; Canani LH; Gross JL; Azevedo MJ
    Nephrol Dial Transplant; 2009 Apr; 24(4):1193-6. PubMed ID: 19015170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The cellular basis of albuminuria.
    Mathieson PW
    Clin Sci (Lond); 2004 Dec; 107(6):533-8. PubMed ID: 15333020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The glomerular filter: an imperfect barrier is required for perfect renal function.
    Comper WD; Russo LM
    Curr Opin Nephrol Hypertens; 2009 Jul; 18(4):336-42. PubMed ID: 19474730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathophysiology of diabetic nephropathy.
    Sego S
    Nephrol Nurs J; 2007; 34(6):631-3. PubMed ID: 18203571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Microalbuminuria. An important marker for diabetic nephropathy and macrovascular disease].
    Bangstad HJ; Dahl-Jørgensen K; Aagenaes O; Hanssen KF; Kierulf P
    Tidsskr Nor Laegeforen; 1988 Sep; 108(26):2168-70. PubMed ID: 3206421
    [No Abstract]   [Full Text] [Related]  

  • 27. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM; Mauer M;
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The etiology of proteinuria in diabetic patients.
    Romoşan I; Caraba A; Golea O
    Med Pregl; 2007; 60 Suppl 2():74-7. PubMed ID: 18928163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 'Microalbuminuric anaemia'--the relationship between haemoglobin levels and albuminuria in diabetes.
    Adetunji OR; Mani H; Olujohungbe A; Abraham KA; Gill GV
    Diabetes Res Clin Pract; 2009 Aug; 85(2):179-82. PubMed ID: 19481284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kidney function and glomerular permeability to macromolecules in juvenile diabetes with special reference to early changes.
    Mogensen CE
    Dan Med Bull; 1972 Sep; 19():Suppl 3:1-40. PubMed ID: 4642311
    [No Abstract]   [Full Text] [Related]  

  • 31. The current clinical problems for early phase of diabetic nephropathy and approach for pathogenesis of diabetic nephropathy.
    Doi T; Mima A; Matsubara T; Tominaga T; Arai H; Abe H
    Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S21-4. PubMed ID: 18842318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Where does albuminuria come from in diabetic kidney disease?
    Comper WD; Russo LM
    Curr Diab Rep; 2008 Dec; 8(6):477-85. PubMed ID: 18990305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genome-wide linkage scans for renal function and albuminuria in Type 2 diabetes mellitus: the Diabetes Heart Study.
    Freedman BI; Bowden DW; Rich SS; Xu J; Wagenknecht LE; Ziegler J; Hicks PJ; Langefeld CD
    Diabet Med; 2008 Mar; 25(3):268-76. PubMed ID: 18307454
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined therapy of rhein and benazepril on the treatment of diabetic nephropathy in db/db mice.
    Jia ZH; Liu ZH; Zheng JM; Zeng CH; Li LS
    Exp Clin Endocrinol Diabetes; 2007 Oct; 115(9):571-6. PubMed ID: 17943690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microalbuminuria--a biomarker of renal microvascular disease.
    Futrakul N; Sridama V; Futrakul P
    Ren Fail; 2009; 31(2):140-3. PubMed ID: 19212911
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urinary Smad1 is a novel marker to predict later onset of mesangial matrix expansion in diabetic nephropathy.
    Mima A; Arai H; Matsubara T; Abe H; Nagai K; Tamura Y; Torikoshi K; Araki M; Kanamori H; Takahashi T; Tominaga T; Matsuura M; Iehara N; Fukatsu A; Kita T; Doi T
    Diabetes; 2008 Jun; 57(6):1712-22. PubMed ID: 18285555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Different roles for TGF-beta and VEGF in the pathogenesis of the cardinal features of diabetic nephropathy.
    Ziyadeh FN
    Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S38-41. PubMed ID: 18842317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Orally administered microencapsulated lysozyme downregulates serum AGE and reduces the severity of early-stage diabetic nephropathy.
    Cocchietto M; Zorzin L; Toffoli B; Candido R; Fabris B; Stebel M; Sava G
    Diabetes Metab; 2008 Dec; 34(6 Pt 1):587-94. PubMed ID: 18926757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glomerular pore size corresponding to albumin molecular size, an explanation for underlying structural pathology leading to albuminuria at nanolevel.
    Wiwanitkit V
    Ren Fail; 2006; 28(1):101. PubMed ID: 16526328
    [No Abstract]   [Full Text] [Related]  

  • 40. Lowering of proteinuria in response to antihypertensive therapy predicts improved renal function in late but not in early diabetic nephropathy: a pooled analysis.
    Jerums G; Panagiotopoulos S; Premaratne E; Power DA; MacIsaac RJ
    Am J Nephrol; 2008; 28(4):614-27. PubMed ID: 18285683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.